A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Biogen Inc. stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 31,709 shares of BIIB stock, worth $4.47 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
31,709
Previous 31,981 0.85%
Holding current value
$4.47 Million
Previous $7.41 Million 17.09%
% of portfolio
0.04%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$189.07 - $236.8 $51,427 - $64,409
-272 Reduced 0.85%
31,709 $6.15 Million
Q2 2024

Aug 12, 2024

BUY
$190.52 - $236.72 $32,769 - $40,715
172 Added 0.54%
31,981 $7.41 Million
Q1 2024

May 08, 2024

BUY
$212.02 - $267.71 $16,537 - $20,881
78 Added 0.25%
31,809 $6.86 Million
Q4 2023

Feb 09, 2024

BUY
$222.59 - $267.94 $581,405 - $699,859
2,612 Added 8.97%
31,731 $8.21 Million
Q3 2023

Nov 09, 2023

BUY
$253.3 - $285.89 $981,790 - $1.11 Million
3,876 Added 15.35%
29,119 $7.48 Million
Q2 2023

Aug 09, 2023

BUY
$275.25 - $318.06 $228,732 - $264,307
831 Added 3.4%
25,243 $7.19 Million
Q1 2023

May 09, 2023

BUY
$256.56 - $292.34 $18,215 - $20,756
71 Added 0.29%
24,412 $6.79 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $786,350 - $955,432
3,115 Added 14.68%
24,341 $6.74 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $18,884 - $26,040
-97 Reduced 0.45%
21,226 $5.67 Million
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $312,816 - $371,997
1,668 Added 8.49%
21,323 $4.35 Million
Q1 2022

May 12, 2022

BUY
$193.77 - $244.14 $235,818 - $297,118
1,217 Added 6.6%
19,655 $4.14 Million
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $53,292 - $68,489
-238 Reduced 1.27%
18,438 $4.42 Million
Q3 2021

Nov 10, 2021

SELL
$282.99 - $369.05 $52,919 - $69,012
-187 Reduced 0.99%
18,676 $5.29 Million
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $48,951 - $78,380
-189 Reduced 0.99%
18,863 $6.53 Million
Q1 2021

May 12, 2021

SELL
$242.95 - $284.63 $42,759 - $50,094
-176 Reduced 0.92%
19,052 $5.33 Million
Q4 2020

Feb 12, 2021

BUY
$236.26 - $355.63 $1.08 Million - $1.62 Million
4,560 Added 31.09%
19,228 $4.71 Million
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $1.41 Million - $1.63 Million
5,337 Added 57.2%
14,668 $4.16 Million
Q2 2020

Aug 11, 2020

SELL
$258.66 - $342.55 $568,276 - $752,582
-2,197 Reduced 19.06%
9,331 $2.5 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $24,734 - $31,375
-92 Reduced 0.79%
11,528 $3.65 Million
Q4 2019

Feb 11, 2020

SELL
$220.06 - $304.07 $43,791 - $60,509
-199 Reduced 1.68%
11,620 $3.45 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $697,330 - $782,123
3,207 Added 37.24%
11,819 $2.75 Million
Q2 2019

Aug 13, 2019

SELL
$219.29 - $241.72 $633,309 - $698,087
-2,888 Reduced 25.11%
8,612 $2.01 Million
Q1 2019

May 07, 2019

BUY
$216.71 - $338.96 $110,088 - $172,191
508 Added 4.62%
11,500 $2.72 Million
Q4 2018

Feb 11, 2019

SELL
$278.5 - $352.75 $1.54 Million - $1.95 Million
-5,539 Reduced 33.51%
10,992 $3.31 Million
Q3 2018

Nov 08, 2018

SELL
$293.51 - $383.83 $1.63 Million - $2.13 Million
-5,558 Reduced 25.16%
16,531 $5.84 Million
Q2 2018

Aug 03, 2018

BUY
$257.52 - $306.91 $813,248 - $969,221
3,158 Added 16.68%
22,089 $6.41 Million
Q1 2018

May 09, 2018

BUY
$260.13 - $367.91 $4,942 - $6,990
19 Added 0.1%
18,931 $5.18 Million
Q4 2017

Feb 13, 2018

BUY
$307.64 - $344.58 $528,217 - $591,643
1,717 Added 9.99%
18,912 $6.03 Million
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $4.83 Million - $5.67 Million
17,195
17,195 $5.38 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.